Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease

The Alzheimer's disease (AD) epidemic is a looming crisis, with an urgent need for new therapies to delay or prevent symptom onset and progression. There is growing awareness that clinical trials must target stage-appropriate pathophysiological mechanisms to effectively develop disease-modifyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalermpalanupap, Termpanit, Kinkead, Becky, Hu, William T, Kummer, Markus P, Hammerschmidt, Thea, Heneka, Michael T, Weinshenker, David, Levey, Allan I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706916/
https://www.ncbi.nlm.nih.gov/pubmed/23634965
http://dx.doi.org/10.1186/alzrt175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706916/
https://www.ncbi.nlm.nih.gov/pubmed/23634965
http://dx.doi.org/10.1186/alzrt175

Ejemplares similares